- Home
- BCV vs ICAD Comparison
BCV vs ICAD Comparison
Compare BCV & ICAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCV
- ICAD
- Stock Information
- Founded
- BCV 1971
- ICAD 1984
- Country
- BCV United States
- ICAD United States
- Employees
- BCV N/A
- ICAD N/A
- Industry
- BCV Finance/Investors Services
- ICAD Medical/Dental Instruments
- Sector
- BCV Finance
- ICAD Health Care
- Exchange
- BCV Nasdaq
- ICAD Nasdaq
- Market Cap
- BCV 92.7M
- ICAD 93.9M
- IPO Year
- BCV N/A
- ICAD 1986
- Fundamental
- Price
- BCV $17.60
- ICAD $3.60
- Analyst Decision
- BCV
- ICAD Hold
- Analyst Count
- BCV 0
- ICAD 1
- Target Price
- BCV N/A
- ICAD N/A
- AVG Volume (30 Days)
- BCV 26.3K
- ICAD 1.8M
- Earning Date
- BCV 01-01-0001
- ICAD 05-19-2025
- Dividend Yield
- BCV 8.13%
- ICAD N/A
- EPS Growth
- BCV N/A
- ICAD N/A
- EPS
- BCV N/A
- ICAD N/A
- Revenue
- BCV N/A
- ICAD $19,608,000.00
- Revenue This Year
- BCV N/A
- ICAD $2.58
- Revenue Next Year
- BCV N/A
- ICAD $14.78
- P/E Ratio
- BCV N/A
- ICAD N/A
- Revenue Growth
- BCV N/A
- ICAD 13.22
- 52 Week Low
- BCV $14.09
- ICAD $1.18
- 52 Week High
- BCV $18.11
- ICAD $3.78
- Technical
- Relative Strength Index (RSI)
- BCV 62.34
- ICAD 72.92
- Support Level
- BCV $16.62
- ICAD $3.42
- Resistance Level
- BCV $17.39
- ICAD $3.58
- Average True Range (ATR)
- BCV 0.34
- ICAD 0.13
- MACD
- BCV 0.16
- ICAD 0.03
- Stochastic Oscillator
- BCV 95.56
- ICAD 78.08
About BCV Bancroft Fund Ltd.
Bancroft Fund Ltd is a diversified closed-end management company. It operates as a closed-ended equity mutual fund. The funds' main objective is to provide income and potential for capital appreciation. With the intent to achieve its objective, the company invests in convertible and equity securities. It invests across different industries such as Computer Software and Services, Energy and Utilities, Health Care among others.
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment includes image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.